Extensive Hippocampal Demyelination in Multiple Sclerosis

Abstract Memory impairment is especially prominent within the spectrum of cognitive deficits in multiple sclerosis (MS), and a crucial role for hippocampal pathology may therefore be expected in this disease. This study is the first to systematically assess hippocampal demyelination in MS. Hippocampal tissue samples of 19 chronic MS cases and 7 controls with non-neurologic disease were stained immunohistochemically for myelin proteolipid protein. Subsequently, number, location, and size of demyelinated lesions were assessed. Furthermore, the specimens were stained for HLA-DR to investigate microglia/macrophage activity. An unexpectedly high number of lesions (n = 37) was found in 15 of the 19 MS cases. Mixed intrahippocampal-perihippocampal lesions, which were more often found in cases with cognitive decline, were large and did not respect anatomical borders. Moderate microglial activation was frequently observed at the edges of these mixed lesions. Isolated intrahippocampal lesions were also frequently found. These were smaller than the mixed lesions and had a specific anatomical predilection: the cornu ammonis 2 subregion and the hilus of the dentate gyrus were consistently spared. Microglial activation was rare in isolated intrahippocampal lesions. Our results indicate that hippocampal demyelination is frequent and extensive in MS and that anatomical localization, size, and inflammatory activity vary for different lesion types.

[1]  Frederik Barkhof,et al.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. , 2007, Archives of neurology.

[2]  C. Elger,et al.  A new clinico-pathological classification system for mesial temporal sclerosis , 2007, Acta Neuropathologica.

[3]  R. Allegri,et al.  Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis. , 2006, Neurology India.

[4]  F. Barkhof,et al.  Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. , 2006, Radiology.

[5]  H. Hahn,et al.  Memory performance in multiple sclerosis patients correlates with central brain atrophy , 2006, Multiple sclerosis.

[6]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[7]  James Lowe,et al.  Spinal Cord Gray Matter Demyelination in Multiple Sclerosis—A Novel Pattern of Residual Plaque Morphology , 2006, Brain pathology.

[8]  Hans Lassmann,et al.  Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits? , 2006, Journal of the Neurological Sciences.

[9]  S. Sorbi,et al.  Neocortical volume decrease in relapsing–remitting multiple sclerosis with mild cognitive impairment , 2006, Journal of the Neurological Sciences.

[10]  My-Van Au Duong,et al.  Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis , 2006, Journal of the Neurological Sciences.

[11]  M. Kronbichler,et al.  Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: An fMRI study , 2006, Journal of the Neurological Sciences.

[12]  G. Winocur,et al.  The cognitive neuroscience of remote episodic, semantic and spatial memory , 2006, Current Opinion in Neurobiology.

[13]  Frederik Barkhof,et al.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis , 2006, Magnetic resonance in medicine.

[14]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[15]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[16]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[17]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[18]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[19]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[20]  Marco Rovaris,et al.  Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.

[21]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[22]  M. Rovaris,et al.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. , 2005, AJNR. American journal of neuroradiology.

[23]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[24]  R. Clark,et al.  The medial temporal lobe. , 2004, Annual review of neuroscience.

[25]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[26]  F. Barkhof,et al.  Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis , 2004, Neuropathology and applied neurobiology.

[27]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[28]  D. Swaab,et al.  Impaired hypothalamus‐pituitary‐adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions , 2004, Annals of neurology.

[29]  K. Oguro,et al.  Differential distribution of 68 Kd and 200 Kd neurofilament proteins in the gerbil hippocampus and their early distributional changes following transient forebrain ischemia , 2004, Experimental Brain Research.

[30]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[31]  J. Geurts,et al.  Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. , 2003, Brain : a journal of neurology.

[32]  J. Hodges,et al.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant , 2003, Journal of neurology, neurosurgery, and psychiatry.

[33]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[34]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[35]  A Achiron,et al.  Cognitive impairment in probable multiple sclerosis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[36]  R. Bakshi,et al.  Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[37]  F. H. Lopes da Silva,et al.  Glutamate transporters alterations in the reorganizing dentate gyrus are associated with progressive seizure activity in chronic epileptic rats , 2002, The Journal of comparative neurology.

[38]  Jayaram K. Udupa,et al.  Magnetization Transfer Ratio Histogram Analysis of Normal-Appearing Gray Matter and Normal-Appearing White Matter in Multiple Sclerosis , 2002, Journal of computer assisted tomography.

[39]  W. Kamphorst,et al.  Hypothalamic Lesions in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[40]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[41]  D. Pitt,et al.  Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage , 2001, Annals of neurology.

[42]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[43]  R Bakshi,et al.  Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[44]  A. Pérez-Samartín,et al.  The link between excitotoxic oligodendroglial death and demyelinating diseases , 2001, Trends in Neurosciences.

[45]  J. DeLuca,et al.  A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[46]  M. Blinkenberg,et al.  Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.

[47]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[48]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[49]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[50]  E. Aronica,et al.  Aurintricarboxylic acid prevents GLUR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Miledi,et al.  Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  F. Fazio,et al.  Functional Basis of Memory Impairment in Multiple Sclerosis: A [18F]FDG PET Study , 1996, NeuroImage.

[53]  J. Trojanowski,et al.  Human fetal hippocampal development: I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features , 1996, The Journal of comparative neurology.

[54]  Massimo Filippi,et al.  Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.

[55]  Stephen M. Rao,et al.  Neuropsychology of multiple sclerosis. , 1995, Current opinion in neurology.

[56]  C. Daumas-Duport,et al.  Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[57]  M. Witter,et al.  Morphological and functional correlates of borders in the entorhinal cortex and hippocampus , 1993, Hippocampus.

[58]  C. Cotman,et al.  Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  F. Eckenstein,et al.  Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[61]  J. Oger,et al.  Neuropsychological Performance in Patients With Mild Multiple Sclerosis , 1991, The Journal of nervous and mental disease.

[62]  M. Mehler,et al.  Atypical psychosis with disseminated subpial demyelination. , 1988, Archives of neurology.

[63]  T. Hammeke,et al.  Memory disturbance in chronic progressive multiple sclerosis. , 1984, Archives of neurology.

[64]  Dyal N. P. Singh Atlas of the human brain and spinal cord: line drawings , 1983 .

[65]  K. L. Moore,et al.  An atlas of the human brain and spinal cord , 1982 .

[66]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[67]  C. Vogt,et al.  Sitz und Wesen der Krankheiten im Lichte der topistischen Hirnforschung und des Variierens der Tiere , 1937 .

[68]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.